← Open Payments lookup

CANDICE SHOWS: Open Payments

NPI 1740754027 · COLUMBIA, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$248 in 14 payments from 8 companies in 2025. Trend: 2023 $293 · 2024 $324 · 2025 $248

Food & beverage: $248
CompanyPaymentsAmount
Novo Nordisk Inc4$67
Lilly USA, LLC3$49
AstraZeneca Pharmaceuticals LP2$37
Takeda Pharmaceuticals U.S.A., Inc.1$25
Bayer Healthcare Pharmaceuticals Inc.1$25
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23
Boehringer Ingelheim Pharmaceuticals, Inc.1$16
Phathom Pharmaceuticals, Inc.1$6

Products named: Ozempic, MOUNJARO, BREZTRI, TRINTELLIX, Kerendia, XIFAXAN, JARDIANCE, VOQUEZNA.

Industry payments across MS — which companies pay providers there.